Product Details
Place of Origin: China
Brand Name: Sunshine
Certification: ISO,COA
Model Number: 223673-61-8
Payment & Shipping Terms
Minimum Order Quantity: Negotiation
Price: Negotiation
Packaging Details: Aluminum Foil Bag, Drum
Delivery Time: 7-15 days
Payment Terms: T/T, L/C, D/A, Western Union
Supply Ability: TON
CAS NO:: |
223673-61-8 |
Appearance :: |
White To Off-white Powder |
Molecular Formula:: |
C21H24N4O2S |
Molecular Weight:: |
396.506 |
EINECS NO:: |
800-126-3 |
MDL NO:: |
MFCD11100356 |
CAS NO:: |
223673-61-8 |
Appearance :: |
White To Off-white Powder |
Molecular Formula:: |
C21H24N4O2S |
Molecular Weight:: |
396.506 |
EINECS NO:: |
800-126-3 |
MDL NO:: |
MFCD11100356 |
Product Description:
Product Name: Mirabegron CAS NO:223673-61-8
Synonyms:
N-(4-(2-(2-hydroxy-2-phenylethylamino)ethyl)phenyl)-2-(2-aminothiazol-4-yl)acetamide;
2-Amino-N-[4-[2-[[(2R)-2-hydroxy-2-phenyl-ethyl]amino]-ethyl]phenyl]-4-thiazoleacetamide;
2-(2-amino-1,3-thiazol-4-yl)-N-(4-{2-[(2-hydroxy-2-phenylethyl)amino]ethyl}phenyl)acetamide;
Chemical & Physical Properties:
Appearance : White to off-white powder
Assay :≥99.0%
Density:1.3g/cm3
Boiling Point:690℃ at 760 mmHg
Flash Point: 371.1℃
Melting point:137-142℃
Mirabegron was developed by Japan's Astellas Pharmaceutical Company, and was listed in Japan on September 16, 2011, and was approved by the U.S. Food and Drug Administration (FDA) on June 28, 2012. Treatment of overactive bladder (OAB) in adults. Mirabegron is the first β3 adrenergic receptor agonist drug used for the treatment of overactive bladder, and its successful listing fills the gap in the treatment of overactive bladder.
If you are interested in our products or have any questions, please feel free to contact us!
Products under patent are offered for R & D purpose only. However, the final responsibility lies exclusively with the buyer.
